Effects of 5-aminolevulinic acid-mediated sonodynamic therapy on macrophages

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 669-676

  Cheng, Jiali ^a   Sun, Xin ^a,b   Guo, Shuyuan ^a   Cao, Wei ^a   Chen, Haibo ^a   Jin, Yinghua ^a   Li, Bo ^a   Li, Qiannan ^a   Wang, Huan ^a   Wang, Zhu ^c   Zhou, Qi ^c   Wang, Peng ^c   Zhang, Zhiguo ^c   Cao, Wenwu ^c,d   Tian, Ye ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

5 aminolevulinic acid; Atherosclerosis; Macrophage; Protoporphyrin IX; Sonodynamic therapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; AMINOLEVULINIC ACID; PROPIDIUM IODIDE; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL ASSAY; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INCUBATION TIME; MACROPHAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; SONODYNAMIC THERAPY; SPECTROFLUOROMETRY; ULTRASOUND THERAPY; ULTRASOUND TRANSDUCER;

5-AMINOLEVULINIC ACID; ATHEROSCLEROSIS; MACROPHAGE; PROTOPORPHYRIN IX; SONODYNAMIC THERAPY;

AMINOLEVULINIC ACID; ANALYSIS OF VARIANCE; CELL DEATH; CELL LINE; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES; ULTRASONIC THERAPY; ULTRASONICS;

EID: 84873970216     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S39844     Document Type: Article

References (27)

1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917): 868-874.
2. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341-355.
3. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17(11):1410-1422.
4. Tiwari RL, Singh V, Barthwal MK. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev. 2008;28(4): 483-544.
5. De Meyer I, Martinet W, De Meyer GR. Therapeutic strategies to deplete macrophages in atherosclerotic plaques. Br J Clin Pharmacol. 2012;74(2):246-263.
6. Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem. 2004;11(6):349-363.
7. Shibaguchi H, Tsuru H, Kuroki M. Sonodynamic cancer therapy: a non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer Res. 2011;31(7):2425-2429.
8. Gao Q, Wang F, Guo S, et al. Sonodynamic effect of an anti-inflammatory agent - emodin on macrophages. Ultrasound Med Biol. 2011;37(9):1478-1485.
9. Krammer B, Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci. 2008;7(3):283-289.
10. Song W, Cui H, Zhang R, et al. Apoptosis of SAS cells induced by sonodynamic therapy using 5-aminolevulinic acid sonosensitizer. Anticancer Res. 2011;31(1):39-45.
11. Wang X, Wang P, Tong W, Liu Q. Comparison of pharmacokinetics, intracellular localizations and sonodynamic efficacy of endogenous and exogenous protoporphyrin IX in sarcoma 180 cells. Ultrasonics. 2010;50(8):803-810.
12. Mi N, Liu Q, Wang X, et al. Induction of sonodynamic effect with protoporphyrin IX on isolate hepatoma-22 cells. Ultrasound Med Biol. 2009;35(4):680-686.
13. Wang XB, Liu QH, Wang P, et al. Study of cell killing effect on S180 by ultrasound activating protoporphyrin IX. Ultrasonics. 2008;48(2): 135-140.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
15. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250-281.
16. Waksman R, McEwan PE, Moore TI, et al. PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression. J Am Coll Cardiol. 2008;52(12):1024-1032.
17. Peng C, Li Y, Liang H, et al. Detection and photodynamic therapy of inflamed atherosclerotic plaques in the carotid artery of rabbits. J Photochem Photobiol B. 2011;102(1):26-31.
18. Xiang J, Xia X, Jiang Y, et al. Apoptosis of ovarian cancer cells induced by methylene blue-mediated sonodynamic action. Ultrasonics. 2011;51(3):390-395.
19. Martinet W, Verheye S, De Meyer GR. Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell death. Trends Cardiovasc Med. 2007;17(2):69-75.
20. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10(1):36-46.
21. Lv Y, Fang M, Zheng J, et al. Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma. Cell Physiol Biochem. 2012;30(2):321-333.
22. Kim CH, Chung CW, Choi KH, et al. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int J Nanomedicine. 2011;6:1357-1363.
23. Kinoshita M, Hynynen K. Mechanism of porphyrin-induced sonodynamic effect: possible role of hyperthermia. Radiat Res. 2006;165(3):299-306.
24. Li Y, Wang P, Zhao P, et al. Apoptosis induced by sonodynamic treatment by protoporphyrin IX on MDA-MB-231 cells. Ultrasonics. 2012;52(4):490-496.
25. Ji Z, Yang G, Vasovic V, et al. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B. 2006;84(3):213-220.
26. Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 2003;8(2):115-128.
27. Mates JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 2000;153(1-3):83-104.